A couple of interesting papers came out in the last few days. One reported on ICU patients given anakinra, an interleukin 1 blocker. They had much better survival than patients not given it. Interleukin 1 is a strong contributor toward cytokine storm. The other paper reported on tocilizumab, an interleukin 6 blocker. Again, much better survival. Interleukin 6 is another signalling component of cytokine storm. The good thing is these are both useful treatments for seriously ill patients. The interesting thing is they are both prescribed to treat rheumatoid arthritis, like hydroxychloroquine! Small world, isn't it?
The MATH+ Protocol has actually added both to their Salvage Treatments section. This for the patients still declining when their full protocol has been used. These guys are right on top of new information coming out.
Another paper from France looked at over three thousand patients, some of whom received very early HCQ and azithromycin, versus others that did not. I did not track down the actual paper, but they did mention declining blood zinc values. Very significant benefit with the HCQ. But of course HCQ is kryptonite now, so nobody in American will pay any attention.